USE OF THYMOSIN IN TREATMENT OF PRIMARY IMMUNODEFICIENCY DISEASES AND CANCER

被引：74

作者：

GOLDSTEIN, AL ^{[1
]}

COHEN, GH ^{[1
]}

ROSSIO, JL ^{[1
]}

THURMAN, GB ^{[1
]}

BROWN, CN ^{[1
]}

ULRICH, JT ^{[1
]}

机构：

[1] UNIV TEXAS,MED BRANCH,DIV BIOCHEM,GALVESTON,TX 77550

来源：

关键词：

D O I：

10.1016/S0025-7125(16)31900-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：591 / 606

页数：16

共 78 条

[1] AMMAN AJ, MODULATION HOST RESI
[2] REDUCTION IN INCIDENCE OF WASTING DISEASE IN NEONATALLY THYMECTOMIZED CBA/W MICE BY INJECTION OF THYMOSIN
ASANUMA, Y
GOLDSTEIN, AL
WHITE, A
[J]. ENDOCRINOLOGY, 1970, 86 (03) : 600 - +
[3] APPEARANCE OF T-CELL MARKERS IN BONE MARROW ROSETTE-FORMING CELLS AFTER INCUBATION WITH THYMOSIN, A THYMIC HORMONE
BACH, JF
DARDENNE, M
GOLDSTEIN, AL
GUHA, A
WHITE, A
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1971, 68 (11) : 2734 - +
[4] BACH JF, 1975, BIOLOGICAL ACTIVITY, P173
[5] BARKER AR, COMMUNICATION
[6] CATALONA WJ, 1973, CANCER, V31, P353, DOI 10.1002/1097-0142(197302)31:2<353::AID-CNCR2820310213>3.0.CO
[7] 2-B
[8] CATALONA WJ, 1973, CANCER, V31, P65, DOI 10.1002/1097-0142(197301)31:1<65::AID-CNCR2820310109>3.0.CO
[9] 2-Y
[10] CERCEK L, 1975, IMMUNOLOGY, V29, P885